A $9 billion biotech deal
People
-
Todd Bishop Host
-
John Cook Host
-
Claire McGinn Host
Listen on
One of the most prominent immunotherapy companies, Juno Therapeutics, announced a deal to be acquired by Celgene. Plus, we dive into the tech renaissance in Pittsburgh and complain about Seattle's bike lanes. Read all our coverage at GeekWire.com. See omnystudio.com/listener for privacy information.
Chapters
- 0:00 Geek Wire's HQ2 in Pittsburgh
- 3:26 Pittsburgh's Tech Renaissance
- 5:55 Life Sciences in Pittsburgh
- 8:20 Amazon HQ2 Bidding Process
- 17:35 Fred Hutch Obliteride
- 18:13 Juno Therapeutics Acquired by Celgene
- 18:45 Juno's Immunotherapy Research
- 20:32 Juno's Clinical Trial Setbacks